Genetic information can improve administration of anticoagulant

Each year in the United States, doctors start about 2 million patients on warfarin (Coumadin), an anticoagulant drug that's notoriously hard to administer. Now a study from the International Warfarin Pharmacogenetics Consortium (IWPC), which includes researchers from Washington University School of Medicine in St. Louis, confirms that using a patient's genetic information can make it easier to get the warfarin dose right...

Read the whole article on

More from